I was born in the former Democratic Republic of Germany (DDR) and grew up in East Berlin. I went to school and University as well in East Berlin. After graduating from Humboldt University, I went to Budapest to further my education. This was the first city where, already in 1984/84, I experienced a more open and tolerant society, not the paralyzing confinement of the DDR. The feeling of freedom I have never forgotten since.
Back in the DDR after a year in Hungary, life there turned impossible for me. I escaped to the Federal Republic of Germany (BRD) and continued my education as a Neurosurgeon. After the wall fell I went to work at the University Clinic in Sheffield, England, for 18 months.
Back in Germany I started to work for the University Hospital in Aachen as Head of Neurosurgery. After a very intensive time there I was offered the position of Head of the Clinic in Zwickau. My experiences with minimally invasive operating methods lead to an increased interest in the field of endoscopic treatment methods of the spinal canal. As the result of extensive research work I habilitated in the field of Thecaloscopy at the Neurological Department of the University of Mainz. Simultaneously I received my appointment as Professor of Health Management at the University of Applied Sciences Zwickau. The extensive scientific work with the diseases of the spinal cord and its meninx as well as the practical experiences in the daily medical field were the basis for my interest in the treatment of diseases of the Leptomeninges (soft skins), specifically Arachnoiditis and Tarlov Cysts.
This biography should serve not only to provide some information on my background but more to reiterate my open questions with respect to the research emphasis of the Vigdis Thompson Foundation. It is so very important to find the underlying causes for Arachnoiditis and Tarlov Cysts. Why do some patients fall victim to these terrible diseases after injections or bleeding accidents and others do not? What are the mechanisms of the development of these diseases? Which factors initiate and further their development?
Only the answers to these questions will make it possible to help the affected patients, so that their disease is recognized by the medical community and thus to offer a targeted therapy as early as possible. One thing common to all the patients world-wide: they are often not taken seriously by medical professionals due to the limited knowledge about these diseases.